Innovating in the biomedical field, the company focuses on research, development, production and sale of biomaterials and tissue engineering scaffolds. Bio-lu Company used this patent to develop many different products such as hydroxyapatite bioceramics and ß-tricalcium phosphate bioceramics (commercial name : Bio-lu) officially recognised by the State Food and Drug Administration (SFDA) of the Pe
ople’s Republic of China. Since 2002, these products have been marketed and used in hundreds of hospitals and for more than 50 000 patients so far without causing any rejection, inflammation, allergy or any other adverse effect. This structure is stable, compatible with human biologic structures, is absolutely safe and provides an excellent bone conduction. Trying to reach the best quality for its structure, improving its production process and developing new products in the same time, Bio-lu Company keeps on improving the structure’s synthesis technique and increasing the investments. In 2007, the company has created various labs for microorganism study, chemistry, physics, histology and cell culture. Moreover, in 2008, the laboratory has started a hard tissue (non-decalcified) histological section centre in order to observe newly formed tissue inside the implant and also the interfacial reactions between bones and biomaterials.
